TAG:
mergers and acquisitions
An Insider’s Observances of Lab Outreach Deals
By R. Lewis Dark | From the Volume XXXII, No. 12 – August 25, 2025 Issue
THERE ARE MANY WAYS TO VIEW CLINICAL LABORATORY OUTREACH ACQUISITIONS and the enormous amount of money changing hands in these deals. From one point of view, those fearful of the continued expansion of national lab giants like Labcorp and Quest Diagnostics may shive…
What’s Behind the Surge in Lab Outreach Sales?
By Janette Wider | From the Volume XXXII, No. 12 – August 25, 2025 Issue
CEO SUMMARY: The recent CHS-Labcorp deal is one of many that highlights a market shift. Clinical lab outreach services, once viewed as strategic assets, are being sold off rapidly as hospitals recenter around core services and offload logistical burdens. This year, 30% of …
Regional Health Systems Are New Dominant Players in M&A
By Scott Wallask | From the Volume XXXII, No. 9 – June 23, 2025 Issue
READERS OF THE DARK REPORT UNDERSTAND HOW INTERTWINED THEIR CLINICAL LAB BUSINESS is with healthcare system mergers and acquisitions (M&A). Thus, financial service firm Morgan Stanley’s recent report on M&A activity in the healthcare industry will be of inte…
Kaiser Acquires Geisinger Health in Value-Based Deal
By Robert Michel | From the Volume XXX, No. 7 – May 8, 2023 Issue
CEO SUMMARY: This blockbuster combination of two respected integrated delivery networks (IDNs) caught the hospital industry by surprise. Post-closing, Kaiser and Geisinger will have combined revenue…
Pandemic Helped Lab with Hospital Leaders
By Scott Wallask | From the Volume XXX No. 3 – February 13, 2023 Issue
CEO SUMMARY: Growth at Atrium Health during the COVID-19 pandemic elevated its clinical laboratory’s profile with medical leaders and health system administrators. What followed was a new spirit of collaboration that led to lab involvement in cost savings efforts, such as improved…
CURRENT ISSUE

Volume XXXII, No. 12 – August 25, 2025
In an exclusive interview, a laboratory industry M&A specialist discusses what’s driving lab outreach sales to national lab companies. Also, The Dark Report analyzes ways in which pathology and clinical labs can profitably partner with pharmaceutical companies.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized